Orpea (ORPEF) Stock Price, News & Analysis

Company Overview

Orpea SA, trading on the OTC market under the ticker ORPEF, is a France-based provider of post-acute and long-term care services. Founded in 1989 by Jean-Claude Marian, the company has grown into one of Europe’s leading operators of nursing homes and assisted living facilities. Orpea’s operations encompass care for the elderly, specialized rehabilitation centers, and psychiatric and addiction treatment units, offering a continuum of services designed to meet the evolving needs of an aging population.

The company’s core business activities include residential care, medical rehabilitation, and mental health services. Orpea designs and manages its facilities to deliver personalized care plans, combining clinical programs with social and recreational activities. In addition to traditional nursing home services, the group operates memory care units for patients with Alzheimer’s disease and other forms of dementia, as well as post-operative rehabilitation centers that support patients recovering from surgery or serious illness.

Orpea maintains a diversified geographic footprint, with operations spanning over 800 facilities across more than 20 countries in Europe, Latin America, and Asia. This international presence enables the company to leverage best practices in care delivery, while tailoring its offerings to local regulatory and cultural requirements. Under the leadership of a professional management team and with a board that reflects the founder’s vision, Orpea continues to pursue strategic expansion and service innovation in the global healthcare sector.

Key Stats

• Today's Range: $6.60 to $6.60
• 50-Day Range: $6.60 to $6.60
• 52-Week Range: $6.60 to $6.60
• Volume: N/A
• Average Volume: 15,700 shs
• Market Capitalization: N/A
• P/E Ratio: 3.61
• Dividend Yield: 9.09%
• Price Target: N/A
• Consensus Rating: N/A

Orpea Stock Analysis - MarketRank™

Orpea scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Orpea.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Orpea is 3.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.04.

Price to Earnings Ratio vs. Sector

The P/E ratio of Orpea is 3.61, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.25.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Orpea has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Orpea has recently decreased by 1.35%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Orpea pays a meaningful dividend of 1.46%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Orpea does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Orpea is 32.78%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

News Sentiment

Orpea has a news sentiment score of -0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Orpea insiders have not sold or bought any company stock.

Percentage Held by Institutions

24.98% of the stock of Orpea is held by institutions.

ORPEF Stock Analysis - Frequently Asked Questions

How have ORPEF shares performed this year?

Orpea's stock was trading at $6.60 at the start of the year. Since then, ORPEF shares have increased by 0.0% and is now trading at $6.60.

When did Orpea's stock split?

Shares of Orpea reverse split on the morning of Friday, March 22nd 2024.The 1-1000 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

How do I buy shares of Orpea?

Shares of ORPEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ORPEF
• CIK: N/A
• Web: www.orpea-corp.com
• Phone: (314) 775-7807
• Fax: N/A
• Employees: 76,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 3.61
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A